Sign in Subscribe
Cancer research

Brain Cancer Market Transitions to Targeted Therapies and Immunotherapy Approaches

Strategic Insights

— 1 min read

The brain cancer market is experiencing a significant shift towards targeted therapies and immunotherapy approaches, driven by the discovery of genetic markers and biomarkers associated with brain tumors. This transition is expected to lead to more precision medicine strategies and innovative treatments that can effectively target brain cancer while preserving healthy brain tissue. The global brain cancer market is projected to grow due to the increasing incidence of brain cancer, advancements in medical technology, and the growing focus on personalized medicine.

Key Takeaways:

  • The brain cancer market is transitioning from traditional methods (surgery, chemotherapy) to more targeted therapies and immunotherapy approaches.
  • The discovery of genetic markers and biomarkers associated with brain tumors has led to the development of precision medicine strategies and innovative treatments.
  • Key factors driving the market include the increasing incidence of brain cancer, advancements in medical technology, and the growing focus on personalized medicine.
  • North America holds a dominant position in the global brain cancer market due to its advanced healthcare infrastructure, high diagnosis rates, and strong presence of key pharmaceutical companies.
  • Immunotherapies and personalized treatments tailored to the patient's genetic makeup are gaining traction in the market.
  • Merck & Co., Inc., Novartis AG, and Genentech are some of the prominent names established in this market.
  • The global brain cancer market is expected to grow due to the increasing focus on precision medicine and innovative treatments.

Statistics:

  • The global brain cancer market is expected to reach $14.6 billion by 2035.
  • The North American market is projected to hold 43.6% of the global brain cancer market share by 2025.
  • The Asia-Pacific region is expected to grow at a CAGR of 10.3% from 2023 to 2035.
  • The global brain cancer market is expected to reach $6.8 billion in 2035, growing at a CAGR of 13.1% during the forecast period.

Sources:

  • "Brain Cancer Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" report by ResearchAndMarkets.com.
  • ((Comments on this story may be sent to newsdesk@closeupmedia.com))

Read more